Vistagen Therapeutics (VTGN) Q1 2025 Earnings

Feb 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.51
-0.24
0.03
0.3

Details

Expected EPS
-0.509675
Actual EPS
-0.46
Surprise EPS
0.05
Surprise Percent
+9.75%

Description

⁨Vistagen Therapeutics⁩ (⁦VTGN⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts